# ATP Life Science Ventures, L.P.

> Institutional holdings reported to the SEC as of Q1 2021 on Form 13F. CIK 1593440. Source: https://holderbook.com/funds/1593440-atp-life-science-ventures-l-p/

- Reported value: $898.3M
- Positions: 3
- Weight of the ten largest: 100.0%
- Filed: 2021-05-12

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| STOKE THERAPEUTICS INC | [STOK](https://holderbook.com/stocks/STOK/) | $666.6M | 17,161,713 | 74.2% | 6 |
| AKERO THERAPEUTICS INC | [AKRO](https://holderbook.com/stocks/AKRO/) | $169.1M | 5,830,203 | 18.8% | 6 |
| CHINOOK THERAPEUTICS INC | [KDNY](https://holderbook.com/stocks/KDNY/) | $62.6M | 4,028,937 | 7.0% | 2 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q1 2021 | $898.3M | 3 |
| Q4 2020 | $1.3B | 3 |
| Q3 2020 | $741.7M | 2 |
| Q2 2020 | $526.7M | 2 |
| Q1 2020 | $499.2M | 2 |
| Q4 2019 | $595.5M | 2 |